secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001628280-25-022394
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth Q1 revenue down 1.8% to $778M; net loss widens; guides FY25 lower on asset sales
--------------------------------------------------------------------------------

- Net revenue $777.9M (-1.8% YoY); net loss $7.2M vs $2.1M loss prior year.
- Adjusted EBITDA $127.9M (-19.3% YoY); operating cash flow improved to $95.5M.
- Sold incontinence assets; signed deal to sell infusion assets (closes Q2 2025).
- FY2025 guidance reduced: revenue $3.18B-$3.32B, Adj. EBITDA $665M-$705M.
- Diabetes segment improved for second consecutive quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828025022394/0001628280-25-022394-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828025022394/ahco-20250506.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-022394

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer